The researchers examined the incidence rates, risk factors, and outcomes for IL-1 and IL-6 inhibitors in patients with systemic and non-systemic juvenile idiopathic arthritis.
While the long-term safety and efficacy of mepolizumab have been studied, gaps in the literature have remained on the clinical impact of stopping mepolizumab after long-term use. Researchers examined how...
Researchers examined how airway differentiation of eosinophilic progenitor cells may impact non-asthmatic eosinophilic bronchitis and eosinophilic asthma.
Dilation of the esophagus is often used to manage symptoms of dysphagia in patients with eosinophilic esophagitis, but the relationship between dilation, eosinophil concentration, and symptoms in these...
Although immunomodulators are often used to treat HES, a group of rare conditions characterized by a persistently higher than normal level of eosinophils and evidence of organ damage, biologics may be a...
COVID-19 has had an especially substantial effect on those with chronic diseases such as asthma. Researchers examined the impact of various asthma phenotypes as a COVID-19 comorbidity or as a risk factor...
Because the treatment options for eosinophilic gastrointestinal disorders are limited, authors of the ENIGMA study evaluated whether the AK002 antibody could be a therapy option in eosinophilic gastritis...
The researchers of a new phase 3 clinical trial presented at the ACG 2019 Annual Meeting sought to determine the safety and efficacy of budesonide oral suspension in adolescents and adults with EoE.
While the 6-food elimination diet is commonly recommended to reduce symptoms of pediatric EoE, authors of a study presented at DDW sought to determine whether a less-restrictive food-elimination diet could...
